SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ARRAY BIOPHARMA
(NQNM:ARRY Last Sale: 6.09 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ARRY : $6.09)
$293 million Market Cap at September 12, 2013
Employs 270.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
3200 Walnut Street Research Report Earnings Snapshot - Last 11/04/18
Boulder, CO 80301 Fact Sheet
Phone: (303) 381-6600 Financial Statements
Peer Comparison
Annual Reports

R.E. Conway, CEO, K. Koch, Pres., D.L. Snitman, COO
Researches chemoinformatics, integrating combinatorial chemistry, structure-based drug design and throughput screening with genomics data to improve drug quality and predict success. IPO at $7.50 November 16, 2000. Raised $45.0 million, selling 6.0 million shares, 28% of the outstanding. Lead Manager: Lehman Brothers.
Historical Charts    Technical Analysis
No Historical Data available for ARRY

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ARRY $6.09 $ 0 $6.02 $6.15 4,601,173 $3.25 $7.1 48,108
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $292,978

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex